Clinical Trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Spinal Cord Injury.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-11-29; most recent amendment 2025-04-04.
Trial Details
NCT Number NCT05152290
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Spinal Cord Injuries
Enrollment 20 participants
Start Date 2022-07-06
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-08